Literature DB >> 10372829

Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393.

N G Castro1, M C de Mello, F G de Mello, Y Aracava.   

Abstract

1. Dopamine is known to modulate glutamatergic synaptic transmission in the retina and in several brain regions by activating specific G-protein-coupled receptors. We have examined the possibility of a different type of mechanism for this modulation, one involving direct interaction of dopamine with ionotropic glutamate receptors. 2. Ionic currents induced by fast application of N-methyl-D-aspartate (NMDA) were recorded under whole-cell patch-clamp in cultured striatal, thalamic and hippocampal neurons of the rat and in retinal neurons of the chick. Dopamine at concentrations above 100 microM inhibited the NMDA response in all four neuron types, exhibiting an IC50 of 1.2 mM in hippocampal neurons. The time course of this inhibition was fast, developing in less than 100 ms. 3. The D1 receptor agonist (+)-SKF38393 mimicked the effect of dopamine, with an IC50 of 58.9 microM on the NMDA response, while the enantiomer (-)-SKF38393 was ineffective at 50 microM. However, the D1 antagonist R(+)-SCH23390 did not prevent the inhibitory effect of (+)-SKF38393. 4. The degree of inhibition by dopamine and (+)-SKF38393 depended on transmembrane voltage, increasing 2.7 times with a hyperpolarization of about 80 mV. The voltage-dependent block by dopamine was also observed in the presence of MgCl2 1 mM. 5. Single-channel recordings showed that the open times of NMDA-gated channels were shortened by (+)-SKF38393. 6. These data suggested that the site to which the drugs bound to produce the inhibitory effect was distinct from the classical D1-type dopamine receptor sites, possibly being located inside the NMDA channel pore. It is concluded that dopamine and (+)-SKF38393 are NMDA channel ligands.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372829      PMCID: PMC1565957          DOI: 10.1038/sj.bjp.0702479

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Atypical effect of dopamine in modulating the functional inhibition of NMDA receptors of cultured retina cells.

Authors:  J L Do Nascimento; R C Kubrusly; R A Reis; M C De Mello; F G De Mello
Journal:  Eur J Pharmacol       Date:  1998-02-05       Impact factor: 4.432

2.  Blockade of glutamate- and cholinergic ion channels by amantadane derivatives.

Authors:  L G Magazanik; S M Antonov; N N Potap'eva; V E Gmiro; J Johnson
Journal:  Neurosci Behav Physiol       Date:  1996 Jan-Feb

3.  Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines.

Authors:  T F Freund; J F Powell; A D Smith
Journal:  Neuroscience       Date:  1984-12       Impact factor: 3.590

Review 4.  Novel dopamine receptors half a decade later.

Authors:  P Sokoloff; J C Schwartz
Journal:  Trends Pharmacol Sci       Date:  1995-08       Impact factor: 14.819

5.  Axo-axonic synapses in the rat striatum.

Authors:  J Kornhuber; M E Kornhuber
Journal:  Eur Neurol       Date:  1983       Impact factor: 1.710

6.  Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.

Authors:  C Kaiser; P A Dandridge; E Garvey; R A Hahn; H M Sarau; P E Setler; L S Bass; J Clardy
Journal:  J Med Chem       Date:  1982-06       Impact factor: 7.446

7.  Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons.

Authors:  H Matsubayashi; K L Swanson; E X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  1997-05       Impact factor: 4.030

8.  Modulatory role of dopamine on excitatory amino acid receptors.

Authors:  O Gandolfi; R Dall'Olio
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1996-05       Impact factor: 5.067

9.  Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.

Authors:  C G Parsons; G Quack; I Bresink; L Baran; E Przegalinski; W Kostowski; P Krzascik; S Hartmann; W Danysz
Journal:  Neuropharmacology       Date:  1995-10       Impact factor: 5.250

10.  Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.

Authors:  J Harvey; M G Lacey
Journal:  J Physiol       Date:  1996-04-01       Impact factor: 5.182

View more
  19 in total

1.  Modulation of Postnatal Neurogenesis by Perinatal Asphyxia: Effect of D1 and D2 Dopamine Receptor Agonists.

Authors:  A Tapia-Bustos; R Perez-Lobos; V Vío; C Lespay-Rebolledo; E Palacios; A Chiti-Morales; D Bustamante; M Herrera-Marschitz; P Morales
Journal:  Neurotox Res       Date:  2016-09-16       Impact factor: 3.911

Review 2.  Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine.

Authors:  Frank J S Lee; Yu-tian Wang; Fang Liu
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  GABAergic circuitry in the opossum retina: a GABA release induced by L-aspartate.

Authors:  K C Calaza; J N Hokoç; P F Gardino
Journal:  Exp Brain Res       Date:  2006-02-25       Impact factor: 1.972

4.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

5.  Dopaminergic contributions to hippocampal pathophysiology in schizophrenia: a computational study.

Authors:  Peter J Siekmeier; David P vanMaanen
Journal:  Neuropsychopharmacology       Date:  2014-01-28       Impact factor: 7.853

Review 6.  Dopaminergic modulation of synaptic transmission in cortex and striatum.

Authors:  Nicolas X Tritsch; Bernardo L Sabatini
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

7.  Local differences in GABA release induced by excitatory amino acids during retina development: selective activation of NMDA receptors by aspartate in the inner retina.

Authors:  Karin da Costa Calaza; Maria Christina Fialho de Mello; Fernando Garcia de Mello; Patrícia Franca Gardino
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

8.  Dopamine and serotonin modulate human GABAρ1 receptors expressed in Xenopus laevis oocytes.

Authors:  Lenin D Ochoa-de la Paz; Argel Estrada-Mondragón; Agenor Limón; Ricardo Miledi; Ataúlfo Martínez-Torres
Journal:  ACS Chem Neurosci       Date:  2011-12-09       Impact factor: 4.418

9.  The rat with oxygen-induced retinopathy is myopic with low retinal dopamine.

Authors:  Nan Zhang; Tara L Favazza; Anna Maria Baglieri; Ilan Y Benador; Emily R Noonan; Anne B Fulton; Ronald M Hansen; P Michael Iuvone; James D Akula
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-19       Impact factor: 4.799

10.  Methamphetamine exposure antagonizes N-methyl-D-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures.

Authors:  Katherine J Smith; Rachel L Self; Tracy R Butler; Michael M Mullins; Layla Ghayoumi; Robert C Holley; John M Littleton; Mark A Prendergast
Journal:  Brain Res       Date:  2007-05-04       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.